Risk Stratification in Acutely Admitted Medical Patients

July 21, 2011 updated by: Ribe County Hospital

The study has three main parts.

  1. To see if we can develop a riskstratification tool that can be used to asses the risk for acutely admitted medical patients for inhospital death, admission to the ICU and death within 30 days of release.
  2. To test existing tool as in 1.
  3. To clarify if it is most reasonable to let the admitting doctor order blood test by clinical judgment or be using a predefined list of tests.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

5900

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Esbjerg, Denmark, 6700
        • Ribe County Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Any patient acutely admitted to the medical department of Ribe County Hospital

Description

Inclusion Criteria:

  • Any patient acutely admitted to the medical department of Ribe County Hospital

Exclusion Criteria:

  • Age below 15 years
  • Unwilling to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
By protocol
Where the test are predefined
By degression
The group where the doctor decided which test are to be taken.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of test taken in each group
Time Frame: Five months
Five months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

October 7, 2008

First Submitted That Met QC Criteria

October 7, 2008

First Posted (Estimate)

October 8, 2008

Study Record Updates

Last Update Posted (Estimate)

July 22, 2011

Last Update Submitted That Met QC Criteria

July 21, 2011

Last Verified

August 1, 2008

More Information

Terms related to this study

Other Study ID Numbers

  • risk stratification

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hematologic Tests

Subscribe